CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Near-infrared radiation via Transcranial LED Therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01538199
NCT01538199N/ACompleted

Evaluation of LED Therapeutic Effect in Depression (ELATED): a Placebo-Controlled, Parallel Study of Efficacy, Tolerability and Acceptability of a Novel Approach in the Community

Paolo Cassano·interventional·Posted Feb 24, 2012·Updated Nov 29, 2017

In Brief

A clinical study evaluating Near-infrared radiation via Transcranial LED Therapy and Sham device for Major Depressive Disorder. Completed, enrolled 28 participants across 2 sites.

Detailed Summary

The purpose of this study is to see if using Transcranial LED Therapy (TLT) using the PhotoMedex's Omnilux NEw-U LED helps improve symptoms of major depressive disorder (MDD). TLT works by briefly delivering near-infrared (non-visible) radiations to the forehead. The radiations penetrate the brain and stimulate the cells \& metabolism. Our goals are * To assess the antidepressant effect of the TLT in depressed subjects. * To assess the safety and tolerability of the TLT in depressed subjects * To assess the acceptability of the TLT in depressed subjects * To pilot test the impact on cognition of the TLT in depressed subjects (Ancillary Study)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 24, 2012
Enrollment StartFeb 1, 2012
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 14.4 years ago

Interventions

Near-infrared radiation via Transcranial LED Therapydevice

The subject will lie down comfortably on a exam bed . The sites of application of TLT (left and right forehead) will be inspected for any skin lesions (e.g. laceration or signs of inflammation) which would contraindicate the treatment. The subject will wear protective eyewear in the form of goggles or eye pads. The staff administering the TLT will be careful not to shine the light in or near the eyes of the subject. The two OLS devices will be secured in position with the use of a Hair Net. The delivery of the TLT is expected to last 20 min total (simultaneous application on the left and right forehead). The subject will be asked to rest for five minutes after the delivery of TLT. The skin at the sites of the application will be inspected again prior to dismissing the subject.

Sham devicedevice

The sham device does not emit near-infrared radiation.